| Literature DB >> 35865821 |
Letícia Busato Migliorini1, Laura Leaden1, Romário Oliveira de Sales1, Nathalia Pellegrini Correa1, Maryana Mara Marins1, Paula Célia Mariko Koga2, Alexandra do Rosario Toniolo3, Fernando Gatti de Menezes3, Marines Dalla Valle Martino2, Jesús Mingorance4, Patricia Severino1.
Abstract
Background: Healthcare-associated infections by carbapenem-resistant Klebsiella pneumoniae are difficult to control. Virulence and antibiotic resistance genes contribute to infection, but the mechanisms associated with the transition from colonization to infection remain unclear. Objective: We investigated the transition from carriage to infection by K. pneumoniae isolates carrying the K. pneumoniae carbapenemase-encoding gene bla KPC (KpKPC).Entities:
Keywords: Carbapenem-resistant Enterobacteriaceae (CRE); Klebsiella pneumoniae; bla KPC gene; gastrointestinal carriage; virulence factors
Mesh:
Substances:
Year: 2022 PMID: 35865821 PMCID: PMC9294314 DOI: 10.3389/fcimb.2022.928578
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 6.073
Figure 1Characterization of KpKPC isolates in carriage and infection groups according to MLST and acquired resistance and virulence genes. (A) Bar graph showing the distribution of KpKPC isolates STs in carriage and infection groups. The most prevalent STs were ST11 and ST437 in both groups. (B) Total number of acquired resistance and virulence genes in carriage and infection groups. (C) Total number of isolates carrying the yersiniobactin (ytb) and colibactin (clb) loci. Both groups (carriage and infection) showed a similar number of acquired genes associated with antimicrobial resistance and virulence.
Univariate analysis of risk factors for K. pneumoniae infection comparing carriers and patients who developed an infection within 30 days following colonization.
| Variable | Carriage (n = 107) | Infection (n = 58) |
|
|---|---|---|---|
| Age mean (SD) | 65 (17.4) | 64.9 (17.8) | 0.74 |
| Male | 69 (65.1) | 36 (62.1) | 0.735 |
| Diabetes mellitus | 14 (13.9) | 4 (7.1) | 0.297 |
| Chronic renal disease | 11 (10.9) | 6 (10.7) | 1.000 |
| Solid organ transplantation | 4(4) | 4 (7) | 0.457 |
| Onco-hematological disease | 2(3.6) | 2(2) | 0.617 |
| Chemotherapy | 2 (2) | 1(1.8) | 1.000 |
| Carbapenems | 51 (50.5) | 28 (51.9) | 1.000 |
| Quinolones | 10 (9.9) | 2 (3.7) | 0.218 |
| Cephalosporins | 35 (34.7) | 21 (38.9) | 0.604 |
| Hospitalization within the last 2 months | 53 (52.5) | 34 (61.8) | 0.312 |
| Central venous catheter | 47(46.5) | 27 (48.2) | 0.869 |
| Gastrointestinal previous diseases | 12 (11.9) | 4 (7.1) | 0.419 |
| Abdominal surgery | 8 (7.9) | 6 (10.7) | 0.519 |
| Ventilation device | 51 (51) | 31 (55.4) | 0.620 |
| ICU/Semi-intensive care unit (vs. other medical wards) | 42 (72.4) | 51 (48.1) | 0.003 |
The P-values for each risk factor were calculated by Fisher’s exact test (categorical variables) or Mann–Whitney test (continuous variables).
Figure 2Relative quantification of CRE and bla KPC-carrying bacteria in carriage and infection groups. (A) Relative intestinal load of CRE in carriage and infection groups. (B) Relative intestinal loads of bacKPC in carriage and infection groups. P-values were calculated using the non-parametric Mann–Whitney test.
Figure 3Intestinal load of CRE and bla KPC-carrying bacteria in association with the infection risk factor “admission to intensive and semi-intensive care units.” (A) Relative intestinal loads of CRE in carriage and infection groups considering admission to ICU, semi-intensive care unit, or medical/surgical clinic. (B) Relative intestinal loads of bacKPC in carriage and infection groups considering admission to ICU, semi-intensive care unit, or medical/surgical clinic. P-values were calculated using the two-way ANOVA test.